XML 90 R80.htm IDEA: XBRL DOCUMENT v3.25.2
Note 15 - Segment and Geographic Information - Schedule of Segment Information (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Total revenue $ 143,942 $ 144,292 $ 434,870 $ 422,372
Segment adjusted operating income (loss) (714) (7,106) (28,218) (47,564)
Amortization of completed technology 6,200 7,200 18,400 21,600
Transformation costs (1) [1] 1,542 1,174 9,771 5,310
Provisions 754 1,701 4,765 5,915
Impairment of intangible assets 0 0 0 4,658
Merger and acquisition costs and costs related to share repurchase (2) [2] 58 74 2,316 4,821
Total operating loss (714) (7,106) (28,218) (47,564)
Interest income, net 4,973 7,925 13,760 27,359
Other income (expense), net (821) (377) 1,539 (127)
Income (loss) before income taxes 3,438 442 (12,919) (20,332)
Developed Technology Rights [Member]        
Amortization of completed technology 2,068 2,047 5,876 5,970
Other Intangible Assets [Member]        
Amortization of completed technology 4,123 5,132 12,499 15,655
Operating Segments [Member]        
Total revenue 143,942 144,292 434,870 422,372
Segment adjusted operating income (loss) 7,917 2,990 7,050 (5,227)
Total operating loss 7,917 2,990 7,050 (5,227)
Segment Reporting, Reconciling Item, Corporate Nonsegment [Member]        
Other unallocated corporate adjustments 86 (32) 41 8
Sample Management Solutions [Member]        
Provisions 300 2,600 1,900  
Sample Management Solutions [Member] | Operating Segments [Member]        
Total revenue 77,707 80,673 238,816 233,816
Segment adjusted operating income (loss) 11,248 3,582 18,177 1,509
Total operating loss 11,248 3,582 18,177 1,509
Multiomics [Member]        
Total revenue 66,235 63,619 196,054 188,556
Provisions 400   2,100  
Multiomics [Member] | Operating Segments [Member]        
Total revenue 66,235 63,619 196,054 188,556
Segment adjusted operating income (loss) (3,331) (592) (11,127) (6,736)
Total operating loss $ (3,331) $ (592) $ (11,127) $ (6,736)
[1] Transformation costs represent non-recurring expenses for strategic projects with anticipated long-term benefits to the Company focused on cost reduction and productivity improvement that do not meet the definition of restructuring charges. These costs are directed at simplifying, standardizing, streamlining, and optimizing the Company’s operations, processes and systems to permanently alter the Company’s operations for the long term. For a project to be considered transformational, successful completion of the project must be expected to bring long-term material benefits to the organization and involve significant changes to process and/or underlying technology. Transformation costs in the period result from actions taken as part of the Company’s 2024 transformation plan and primarily relate to one time asset write downs associated with changes in technology, one time inventory write downs relating to restructuring actions taken in the period, and third-party consulting costs associated with process and systems re-design.
[2] Includes expenses related to governance-related matters.